Cargando…
Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic
INTRODUCTION: Serum creatinine (SCr) testing has been the mainstay of kidney function assessment for decades despite known limitations. Cystatin C (CysC) is an alternative biomarker that is generally less affected than SCr by pertinent non-renal factors in hospitalized patients, such as muscle mass....
Autores principales: | Markos, James Roland, Schaepe, Karen S., Teaford, Hilary R., Rule, Andrew D., Kashani, Kianoush B., Lieske, John C., Barreto, Erin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732069/ https://www.ncbi.nlm.nih.gov/pubmed/33306741 http://dx.doi.org/10.1371/journal.pone.0243618 |
Ejemplares similares
-
Cystatin C: A Primer for Pharmacists
por: Teaford, Hilary R., et al.
Publicado: (2020) -
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
por: Frazee, Erin N, et al.
Publicado: (2014) -
Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS
por: Brown, Caitlin S., et al.
Publicado: (2016) -
A Prospective Evaluation of Novel Renal Biomarkers in Patients With Lymphoma Receiving High-Dose Methotrexate
por: Barreto, Jason N., et al.
Publicado: (2022) -
Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate
por: Barreto, Jason N., et al.
Publicado: (2023)